RPMI 8226 Cells




















Key facts about the RPMI 8226 cell lines
Description | RPMI 8226 cells are a human myeloma cell line that was established in 1966 from the peripheral blood of a 61-year-old male patient with multiple myeloma. This cell line was named after the Roswell Park Memorial Institute (RPMI) where it was developed, and the number 8226 denotes its specific catalog number in the cell bank. The RPMI 8226 cell line is an important model system for studying multiple myeloma and related aspects of plasma cell biology, immunology research, and cancer therapy. RPMI 8226 cells are known to produce and secrete kappa light chains of immunoglobulins, a feature that is often exploited in research studies to investigate antibody production and secretion mechanisms. RPMI 8226 cells exhibit numerous chromosomal abnormalities, which are typical of multiple myeloma cells. These include translocations, deletions, and amplifications that affect various oncogenes and tumor suppressor genes. The human myeloma cell line RPMI 8226 are widely used in drug discovery and development research, and have been used to investigate drug resistance pathways and evaluating combination therapies. In summary, RPMI 8226 cells provide a critical in vitro model for multiple myeloma research, enabling the investigation of the biological and molecular mechanisms underlying this disease and the development of therapeutic strategies. |
---|---|
Organism | Human |
Tissue | Peripheral blood |
Disease | Multiple Myeloma |
Synonyms | RPMI-8226, RPMI.8226, RPMI8226, RPMI no. 8226, RPMI no 8226, RPMI #8226, 8226, RPMI 8226/S, RPMI-8226S, RPMI8226/S, 8226/S, Roswell Park Memorial Institute 8226, GM02132, GM2132, GM 2132, GM02132C, Simpson |
Details
Age | 61 years |
---|---|
Gender | Male |
Morphology | Round cells |
Growth properties | Adherent/suspension |
Identifiers / Biosafety / Citation
Citation | RPMI 8226 (Cytion catalog number 300431) |
---|---|
Biosafety level | 1 |
Genetic profile of the peripheral blood-derived RPMI 8226 cells
Antigen expression | HLA Aw19, B15, B37, Cw2 |
---|---|
Isoenzymes | G6PD, A |
Reverse transcriptase | Negative |
Products | Immunoglobulin light chain |
RPMI-8226 cell culture practices
Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
---|---|
Medium supplements | Supplement the medium with 10% FBS |
Passaging solution | Accutase |
Subculturing | Gather the suspension cells in a 15 ml tube and gently wash the adherent cells with PBS lacking calcium and magnesium (use 3-5 ml for T25 flasks and 5-10 ml for T75 flasks). Apply Accutase (1-2 ml for T25 flasks, 2.5 ml for T75 flasks) ensuring full coverage of the cell layer. Allow the cells to incubate at room temperature for 10 minutes. Following incubation, combine and centrifuge both the suspension and adherent cells. After centrifugation, carefully resuspend the cell pellet and transfer the cell suspension into new flasks containing fresh medium. |
Split ratio | A ratio of 1:2 to 1:4 is recommended |
Seeding density | Start new cultures at 5 x 10^5 viable cells/ml. Subculture at 1-2 x 10^6 cells/ml. Maximum cell density is at 1-2 x 10^6 cell/ml. |
Fluid renewal | 2 to 3 times per week |
Freezing recovery | After thawing allow the cells to recover from the freezing process for at least 24 hours. |
Freeze medium | As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
Handling of cryopreserved cultures |
|
Quality verification
Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
---|---|
STR profile |
Amelogenin: x,x
CSF1PO: 12
D13S317: 11
D16S539: 9
D5S818: 11,13
D7S820: 9,1
TH01: 8
TPOX: 8,11
vWA: 16,18
D3S1358: 16,17
D21S11: 28,29
D18S51: 15,19
Penta E: 16,17
Penta D: 2.2,11
D8S1179: 13
FGA: 19
|
HLA alleles |
A*: '30:01:01, '68:02:01
B*: '15:03:01, '15:10:01
C*: '02:10:01, '03:04:02
DRB1*: '03:01:01, '07:01:01
DQA1*: '02:01:01, '05:01:01
DQB1*: '02:01:01, '02:02:01
DPB1*: '01:01:02G, '13:01:01G
E: '01:01:01, '01:03
|
Required products
Initially designed to support the growth of human leukemic cells in both suspension and monolayer cultures, RPMI 1640 Medium has evolved through modifications by researchers and commercial suppliers to become suitable for a diverse range of mammalian cells. It is exceptionally compatible with cell lines such as HeLa, Jurkat, MCF-7, PC12, PBMC, astrocytes, and carcinomas.
RPMI 1640 Medium stands apart from other cell culture media due to its unique composition. It contains a substantial amount of phosphate, amino acids, and vitamins. Notably, it encompasses biotin, vitamin B12, and PABA, absent in Eagle's Minimal Essential Medium or Dulbecco's Modified Eagle Medium. Moreover, RPMI 1640 Medium exhibits significantly elevated concentrations of vitamins inositol and choline. However, it does not contain proteins, lipids, or growth factors. Consequently, supplementation with 10% Fetal Bovine Serum (FBS) is commonly required to provide optimal conditions for cell growth.
The buffering system of RPMI 1640 Medium relies on sodium bicarbonate and necessitates a 5-10% CO2 environment to maintain a physiologically appropriate pH. The inclusion of the reducing agent glutathione further distinguishes this medium from others.
Quality Control
Sterile-filtered
Storage and Shelf Life
Store at +2°C to +8°C, protected from light.
Once opened, store at 4°C and use within 6–8 weeks.
Shipping Conditions
Ambient temperature
Maintenance
Keep refrigerated at +2°C to +8°C in the dark. Avoid freezing and frequent warming to +37°C, as it reduces product quality.
Do not heat the medium beyond 37°C or use uncontrolled heat sources such as microwave appliances.
If only part of the medium is to be used, remove the required amount and warm it to room temperature before use.
Composition
Category
Components
Concentration (mg/L)
Amino Acids
Glycine
10.00
L-Alanyl-L-Glutamine
434.40
L-Arginine
200.00
L-Asparagine H2O
56.82
L-Aspartic Acid
20.00
L-Cystine 2HCl
65.20
L-Glutamic Acid
20.00
L-Histidine HCl H2O
20.27
L-Hydroxy-L-Proline
20.00
L-Isoleucine
50.00
L-Leucine
50.00
L-Lysine HCl
40.00
L-Methionine
15.00
L-Phenylalanine
15.00
L-Proline
20.00
L-Serine
30.00
L-Threonine
20.00
L-Tryptophan
5.00
L-Tyrosine 2Na 2H2O
28.83
L-Valine
20.00
Vitamins
p-Amino Benzoic Acid
1.00
D-Biotin
0.20
Choline Chloride
3.00
D-Calcium Pantothenate
0.25
Folic Acid
1.00
myo-Inositol
35.00
Nicotinamide
1.00
Pyridoxine HCl
1.00
Riboflavin
0.20
Thiamine HCl
1.00
Vitamin B12
0.005
Inorganic Salts
Ca(NO3)2 4H2O
100.00
KCl
400.00
MgSO4 7H2O
100.00
NaCl
6000.00
NaHCO3
2000.00
Na2HPO4
800.00
Other Components
D-Glucose
2000.00
L-Glutathione Reduced
1.00
Phenol Red Sodium Salt
5.30
Phosphate-buffered saline (PBS) is a widely used buffer solution in biological and chemical research. It plays a crucial role in maintaining the pH balance and osmolarity during various experimental procedures, including tissue processing and cell culture. Our PBS solution is meticulously formulated with high-purity ingredients to ensure stability and reliability in every experiment. The osmolarity and ion concentrations of our PBS closely mimic those of the human body, making it isotonic and non-toxic to most cells.
Composition of Our PBS Solution
Our PBS solution is a pH-adjusted blend of ultrapure-grade phosphate buffers and saline solutions. At a 1X working concentration, it contains:
8000 mg/L Sodium chloride (NaCl)
200 mg/L Potassium chloride (KCl)
1150 mg/L Sodium phosphate dibasic anhydrous (Na2HPO4)
200 mg/L Potassium phosphate monobasic anhydrous (KH2PO4)
This composition ensures an optimal pH and ionic balance, suitable for a wide range of biological applications.
Applications of Our PBS Solution
Our PBS solution is ideal for various applications in biological research. Its isotonic and non-toxic properties make it suitable for substance dilution and cell container rinsing. PBS solutions containing EDTA are effective for disengaging attached and clumped cells. However, divalent metals such as zinc should not be added to PBS, as this can cause precipitation. In such cases, Good's buffers are recommended. Additionally, our PBS solution is an acceptable alternative to viral transport medium for the transport and storage of RNA viruses, including SARS-CoV-2.
Quality Control
Sterile-filtered
Storage and Shelf Life
Store at +2°C to +25°C, protected from light.
Once opened, store at 2°C to 25°C and use within 24 months.
Shipping Conditions
Ambient temperature
Maintenance
Keep refrigerated at +2°C to +8°C in the dark. Avoid freezing and frequent warming to +37°C, as it reduces product quality.
Do not heat the medium beyond 37°C or use uncontrolled heat sources such as microwave appliances.
If only part of the medium is to be used, remove the required amount and warm it to room temperature before use.
Composition
Category
Components
Concentration (mg/L)
Salts
Potassium chloride
200
Potassium phosphate monobasic anhydrous
200
Sodium chloride
8000
Sodium phosphate dibasic anhydrous
1150
Certificate of Analysis (CoA)
Lot Number | Certificate Type | Date | Catalog Number |
---|---|---|---|
300431-130125 | Certificate of Analysis | 23. May. 2025 | 300431 |
300431-1022 | Certificate of Analysis | 23. May. 2025 | 300431 |